PeptiDream Inc. (PPTDF)
7.00
0.00 (0.00%)
USD |
OTCM |
Sep 08, 16:00
PeptiDream Net Income (Quarterly) : -7.182M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -7.182M |
| March 31, 2026 | -5.449M |
| December 31, 2025 | -3.452M |
| September 30, 2025 | -7.426M |
| June 30, 2025 | -7.534M |
| March 31, 2025 | -6.780M |
| December 31, 2024 | -17.10M |
| September 30, 2024 | -2.042M |
| June 30, 2024 | 120.44M |
| March 31, 2024 | -5.675M |
| December 31, 2023 | -3.418M |
| September 30, 2023 | 29.54M |
| June 30, 2023 | -3.492M |
| March 31, 2023 | -1.879M |
| December 31, 2022 | 54.74M |
| September 30, 2022 | 6.836M |
| June 30, 2022 | -2.338M |
| March 31, 2022 | -7.130M |
| December 31, 2021 | 0.8567M |
| September 30, 2021 | 22.56M |
| June 30, 2021 | 1.951M |
| March 31, 2021 | -2.090M |
| December 31, 2020 | 35.86M |
| September 30, 2020 | -1.783M |
| June 30, 2020 | 11.45M |
| Date | Value |
|---|---|
| March 31, 2020 | -3.126M |
| September 30, 2019 | -1.726M |
| June 30, 2019 | 18.88M |
| March 31, 2019 | 0.7862M |
| June 30, 2018 | 29.01M |
| March 31, 2018 | -2.742M |
| December 31, 2017 | 1.022M |
| September 30, 2017 | -5.856M |
| June 30, 2017 | 15.53M |
| March 31, 2017 | -1.638M |
| December 31, 2016 | 0.6506M |
| September 30, 2016 | 2.728M |
| June 30, 2016 | 5.599M |
| March 31, 2016 | 6.341M |
| December 31, 2015 | 1.723M |
| September 30, 2015 | 0.3074M |
| June 30, 2015 | 8.226M |
| March 31, 2015 | -0.3551M |
| December 31, 2014 | 0.6035M |
| September 30, 2014 | -0.2051M |
| June 30, 2014 | 0.4002M |
| March 31, 2014 | -0.215M |
| December 31, 2013 | 1.201M |
| September 30, 2013 | 0.0928M |
| June 30, 2013 | 0.0362M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Pharma Foods International Co., Ltd. | -- |
| NovelStem International Corp. | -0.0858M |
| Brainstorm Cell Therapeutics, Inc. | -3.855M |
| Enlivex Ltd. | 1.243B |
| Summit Therapeutics, Inc. | -215.70M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 28.00M |
| Total Expenses (Quarterly) | 35.18M |
| EPS Diluted (Quarterly) | -0.0559 |
| Enterprise Value | 851.28M |
| Gross Profit Margin (Quarterly) | 43.48% |
| Profit Margin (Quarterly) | -25.65% |
| Earnings Yield | -2.60% |
| Normalized Earnings Yield | -2.603 |